Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04957082 · ClinicalTrials.gov registry record · NA
Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake
A NA study of SARS-CoV2 Infection, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 666
- Enrollment target
- 1
- Study location
NCT04957082 is a NA study of SARS-CoV2 Infection that has completed, run by Michigan State University. The registered enrollment target is 666 participants, below the 1,146-participant average among 6 other SARS-CoV2 Infection trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04957082, a NA study of SARS-CoV2 Infection, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 666 participants
- Enrollment target
- 1
- Study location
Study Summary
This disparities-focused study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among African Americans residing in Flint, Michigan. This iteration will consider individuals recruited from the Flint Registry and assess willingness to participate in a drive-up saliva sample collection taking place at a central location in Flint, Michigan.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Targeted SARS-CoV-2 Communication
- BEHAVIORAL General SARS-CoV-2 Communication
Study Locations (1)
Michigan
- Flint Journal Building - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 666 participants |
| Start Date | 2021-08-04 |
| Est. Completion | 2022-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04957082
The ClinicalTrials.gov registry entry for NCT04957082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 666 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,146-participant average among 6 other SARS-CoV2 Infection trials with a reported enrollment target (42% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SARS-CoV2 Infection appearing as the primary indexed condition, and to 2 interventions - of which Culturally Targeted SARS-CoV-2 Communication is the first listed.
NCT04957082 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04957082 about?
NCT04957082 is a clinical study titled "Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake". This disparities-focused study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among African Americans residing in Flint, Michigan. This iteration will consider individuals recruited from the Flint Registry and assess...
What is the current status of trial NCT04957082?
This trial is currently completed. It is a NA study. The enrollment target is 666 participants. The study started on 2021-08-04. Estimated completion is 2022-12-19.
What conditions does trial NCT04957082 study?
This clinical trial studies the following conditions: SARS-CoV2 Infection.
What interventions are being tested in trial NCT04957082?
The interventions under investigation include: Culturally Targeted SARS-CoV-2 Communication (BEHAVIORAL), General SARS-CoV-2 Communication (BEHAVIORAL).
Who is sponsoring clinical trial NCT04957082?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04957082 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SARS-CoV2 Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Cellular Senescence and COVID-19 Long-Hauler Syndrome
ACTIVE NOT RECRUITING
-
Pediatric COVID Outcomes Study (PECOS)
ACTIVE NOT RECRUITING
-
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
COMPLETED
-
A Retrospective Study of COVID-19 Treatments
COMPLETED
-
COVID-19 SARS-CoV-2 RAST Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.